Mary T. Prenon covers real estate and business. She has been a writer and reporter for over 25 years with various print and broadcast media in New York.
Incorrect low glucose readings over an extended period of time could lead to improper treatment decisions for people living with diabetes, the company said.
Merck said the deal will enable it to expand its portfolio with CD388, a long-acting antiviral aimed at preventing flu in people at high risk of complications.
Incorrect low glucose readings over an extended period of time could lead to improper treatment decisions for people living with diabetes, the company said.
Merck said the deal will enable it to expand its portfolio with CD388, a long-acting antiviral aimed at preventing flu in people at high risk of complications.